AzTrials
AzTrials

Stress, EmotionalEASYNCT07115186

School-Based Intervention to Enhance Resilience and Stress Coping in Rural Chinese Adolescents

A study testing Psychoeducation, guided written therapy and wait-list condition in people with Stress, Emotional and Stress-related Mental Disorders, run by Peking University at 1 site in China.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study aims to evaluate the effectiveness of school-based psychological interventions in improving stress resilience and coping skills among adolescents in rural China. The intervention seeks to reduce stress-related mental health symptoms, including depression, anxiety, and post-traumatic stress, measured using… Read more about this study

Who is it for?
Ages 10 to 18 yearsHealthy volunteers can take part
What is being tested?
Psychoeducation, guided written therapy and wait-list condition
Could I receive a placebo?
No, everyone receives an active treatment
How many people
850 participants
Where
1 siteChina
Study dates
12 May 2025to 31 Dec 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 10 to 18 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • Currently enrolled middle school students attending regular school classes
  • Sufficient functional capacity in hearing, speaking, reading, and writing to participate in intervention activities and assessments.

Who cannot join

  • Individuals assessed to be at high risk of suicide, based on screening or clinical judgment
  • Diagnosis of severe mental disorders (e.g., psychotic disorders, severe mood disorders) that would interfere with participation or require more intensive clinical care

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Feng Junkai, MSc contact

86+15625013745

China1 site, 1 recruiting
  • Biancun middle school

    Hebei, Baoding, 071603

    Liang Yachai, 86+ 03125217599

    Recruiting

Other trials in China

About this study

Official title: Enhancing Stress Resilience and Coping Skills Among Adolescents in Rural China Through School-Based Psychological Interventions: A Cluster Randomized Controlled Trial

This study aims to evaluate the effectiveness of school-based psychological interventions in improving stress resilience and coping skills among adolescents in rural China. The intervention seeks to reduce stress-related mental health symptoms, including depression, anxiety, and post-traumatic stress, measured using validated instruments such as the Patient Health Questionnaire-9 (PHQ-9), the Generalized Anxiety Disorder 7-item scale (GAD-7), and the Child PTSD Symptom Scale for DSM-5 (CPSS-5). (See Appendix for full scale descriptions.)

Participants will be recruited from rural middle schools and randomly assigned to either an intervention group or a wait-list control group. The intervention consists of four sessions delivered over one week. Assessments will be conducted at baseline, immediately after the intervention, and again at a 3-month and 6-month follow-ups.

Researchers will use multilevel modeling (MLM) and structural equation modeling (SEM) to examine potential mediators and moderators of intervention effects, including emotion recognition, alexithymia, and coping strategies. indings are expected to provide evidence on the effectiveness and mechanisms of an existing, school-based psychological intervention tailored to the needs of adolescents in underserved rural settings.

Being tested
Psychoeducation, guided written therapy, wait-list condition
Keywords
adolescents, randomized controlled trial, PTSD, depression, anxiety, stress-related mental disorders, rural area
Medical subject headings
Stress, Psychological, Stress Disorders, Post-Traumatic, Depression, Anxiety Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • PsychoeducationBehavioural

    Psychoeducation sessions for adolescents focus on essential topics like stress, emotional distress, and mental disorders, offering foundational knowledge to enhance their understanding and ability to manage these challenges effectively.

  • guided written therapyBehavioural

    In the guided writing intervention, students are asked to write about a recent event that triggered strong emotions on paper and, based on the requirements of each session, attempt to regulate their emotions. This approach aims to enhance students' abilities in emotional identification and emotion regulation.

  • wait-list conditionBehavioural

    Participants will engage in their regular school activities, and after the intervention group completes the program, they will receive the same intervention content as the intervention group.

Study groups in NCT07115186
Study groupRoleWhat they receive
TAU + delayed interventionActive comparatorParticipants in this group will receive treatment as usual (TAU), which includes standard school-based support services. They will not receive the study intervention during the trial period but will be offered the full intervention after final outcome assessments. This design enables comparison between the intervention and existing standard care, while ensuring ethical access to the intervention for all participants.
Receives: Behavioral: wait-list condition
intervention groupExperimentalParticipants in the intervention group will receive a structured psychological program consisting of four sessions delivered over the course of one week. Each session is 40 minutes in duration and includes approximately 20 minutes of psychoeducation followed by 20 minutes of a guided writing intervention. The sessions will cover the following core themes: ① chronic stress and emotional regulation, ② emotional identification and acceptance, ③ cognitive emotion regulation, and ④ the cognitive triangle. Interventions will be administered by trained graduate students in clinical psychology from Peking University. These facilitators will receive specialized training on the intervention protocol, and will conduct pre-intervention assessments and participate in regular supervision. All sessions will be audio and video recorded to monitor treatment fidelity, ensure adherence to the intervention manual, and support supervision and quality assurance procedures.
Receives: Behavioral: Psychoeducation; Behavioral: guided written therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. PTSD for adolescents

    The Child PTSD Symptom Scale for DSM-5 (CPSS-5) for adolescents and children (scores from 0 to 4, and total scores vary from 0 to 80). A higher score represents worse PTSD symptoms.

    Measured: baseline, post treatment (2 weeks after baseline), 3 month after post treatment

  2. Depression

    The 9-item patient health questionnaire (PHQ-9) for adults (score ranges from 0 to 3, and the total score varies from 0 to 27). A higher score indicates worse depression symptoms.

    Measured: baseline, post treatment (2 weeks after baseline), 3 month after post treatment

  3. Insomnia Severity

    The severity of insomnia symptoms will be assessed using the Insomnia Severity Index (ISI). This 7-item self-report measurement evaluates the severity of insomnia symptoms, the level of satisfaction with sleep, interference with daily functioning, noticeability of impairment attributed to sleep problems, and the level of distress caused by sleep disturbance (score from 0 to 4, and total score vary from 0 to 32). Each item is rated on a 5-point scale, providing a comprehensive measure of insomnia severity.

    Measured: baseline, post treatment (2 weeks after baseline), 3 month after post treatment

  4. Generalized anxiety disorder

    The Generalized Anxiety Disorder-7 scale (GAD-7) for adults, adolescents, and children (scored from 0 to 3, and total score from 0 to 21). A higher score represents worse anxiety symptoms.

    Measured: baseline, post treatment (2 weeks after baseline), 3 month after post treatment

  5. Alexithymia

    A 22-item Peking alexithymia scale measures thoughts and behaviors that prevent people from feeling or recognizing negative emotions on a 5-point Likert scale (1 to 5, and total scores vary from 22 to 110). A higher score represents more severe alexithymia.

    Measured: baseline, post treatment (2 weeks after baseline), 3 month after post treatment

  6. Emotion awareness

    A 30-item Emotion awareness questionnaire measures emotion awareness on a 3-point Likert scale (1 to 3, with total scores ranging from 30 to 90). A higher score indicates better emotion awareness.

    Measured: baseline, post treatment (2 weeks after baseline), 3 month after post treatment

Secondary outcomes (7)
  1. Resilience

    The Connor-Davidson resilience scale is a 10-item resilience measurement scale that measures resilience on a 5-point Likert scale (scores range from 0 to 4, and the total score varies from 0 to 40). A higher score represents better resilience.

    Measured: baseline, post treatment (2 weeks after baseline), 3 month after post treatment

  2. Self-esteem

    A 10-item self-esteem measurement scale, Rosenberg self-esteem scale, measures self-esteem on a 4-point Likert scale (score from 0 to 3, and total score varies from 0 to 30), with higher scores indicating greater self-esteem.

    Measured: baseline, post treatment (2 weeks after baseline), 3 month after post treatment

  3. Subjective Happiness Scale

    A 4-item subjective happiness scale measures happiness (score from 1 to 7, and total score vary from 4 to 28). A higher score represents a happier state.

    Measured: baseline, post treatment (2 weeks after baseline), 3 month after post treatment

  4. Frustration

    The 25-item frustration scale (score from 1 to 5, and total score varies from 24 to 120). A higher score represents less frustration.

    Measured: baseline, post treatment (2 weeks after baseline), 3 month after post treatment

  5. Irritability

    A 17-item irritability measurement scale, the Peking irritability scale, measures impulsive emotions, thoughts, and behaviors on a 5-point Likert scale (score from 1 to 5, and total score varies from 17 to 85). A higher score represents higher irritability.

    Measured: baseline, post treatment (2 weeks after baseline), 3 month after post treatment

  6. Cognitive emotion regulation

    An 18-item cognitive emotion regulation questionnaire measures the ability of emotion regulation on a 5-point Likert scale (1 to 5, and total scores vary from 18 to 90). A higher score represents more emotion regulation.

    Measured: baseline, post treatment (2 weeks after baseline), 3 month after post treatment

  7. Game Addiction Scale

    A 7-item game addiction scale measures game addiction on a 5-point Likert scale (score from 1 to 5, and total score varies from 7 to 35), with higher scores indicating worse game addiction.

    Measured: baseline, post treatment (2 weeks after baseline), 3 month after post treatment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Aug 2025
  2. Study start12 May 2025
  3. Primary completion1 Jun 2026 (estimated)
  4. Study completion31 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
850 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07115186
Sponsor's protocol ID
School interv. rural Adolscent
Acronym
EASY
Status last verified
Aug 2025
First submitted
12 May 2025
Last updated
11 Aug 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Psychoeducation, guided written therapy and wait-list condition in people with Stress, Emotional and Stress-related Mental Disorders, run by Peking University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 11 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Zang Yinyin, PhD (+86 15553201610, yinyin.zang@pku.edu.cn), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

PTSD for adolescents (time frame: baseline, post treatment (2 weeks after baseline), 3 month after post treatment). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Aug 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in